A Raleigh-based health care and pharmacy services company has raised $1.95 million in a private equity offering, according to a filing Wednesday with the Securities and Exchange Commission

C3 HealthcareRx raised the money from seven investors, with the lowest investment being $25,000. It is seeking to raise an additional $5.5 million.

The company provides health care and pharmacy services that helps its clients improve health outcomes and generate savings through accurate medication reconciliation, comprehensive medication education, in-home medication reconciliation and effective medication management.

The company has clients in Florida, Kentucky, North Carolina, Ohio and Virginia.

Susan Weaver is the CEO of C3 HealthcareRX. She joined the company in in July 2016 and directs the company’s strategic vision, manages its day-to-day operations, and is responsible for key business relationships nationally.

Weaver was also the founder and president of Transformation Health Partners LLC and chief medical officer at Blue Cross and Blue Shield of North Carolina, the state’s largest health insurer.

Prior to joining BCBSNC, she held various executive positions at WakeMed Health & Hospital, including serving as the organization’s executive vice president of medical affairs and physician practices.

The company claimed a Rule 506 (b) exemption for the filing. Companies relying on the Rule 506 exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.

This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s School of Media and Journalism